Cushing's syndrome due to ectopic ACTH production by (neuroendocrine) prostate carcinoma

被引:23
作者
Alwani, R. A. [1 ,4 ]
Neggers, S. J. C. M. M. [4 ]
van der Klift, M. [3 ]
Baggen, M. G. A. [3 ]
van Leenders, G. J. L. H. [2 ]
van Aken, M. O. [4 ]
van der Lely, A. J. [4 ]
de Herder, W. W. [4 ]
Feelders, R. A. [4 ]
机构
[1] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Dept Pathol, NL-3000 CA Rotterdam, Netherlands
[3] Ikazia Hosp, Dept Internal Med, Rotterdam, Netherlands
[4] Endocrine Sect, Dept Internal Med, Rotterdam, Netherlands
关键词
Ectopic ACTH; Cushing's syndrome; Neuroendocrine differentiation; Prostate cancer; ACTH staining; CLINICAL-FEATURES; CANCER; DIFFERENTIATION; ADENOCARCINOMA; EXPERIENCE; MANAGEMENT; HORMONE; PLASMA; LUNG;
D O I
10.1007/s11102-008-0100-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ectopic adrenocorticotropin (ACTH) secretion accounts for less than 10% of all causes of endogenous Cushing's syndrome (CS) and is usually associated with neuroendocrine tumors and small cell carcinoma of the lung. We report the case of a 62-year-old man with CS due to ectopic ACTH production by small cell carcinoma of the prostate. He presented with severe hypercortisolism and associated symptoms. Plasma neuron specific enolase (NSE) was grossly elevated. Despite performing a laparoscopic bilateral adrenalectomy, the patient died as a result of sepsis with multi-organ failure. Post-mortem immunohistochemical staining of prostate tumor tissue showed ACTH expression. ACTH staining was also performed in four additional patients with small cell carcinoma of the urinary tract without CS. None of these additional cases showed a positive staining for ACTH. Although a rare cause of ectopic ACTH production, neuroendocrine prostate carcinoma should be considered in male patients with Cushing's syndrome, in particular in those with an occult source of ACTH overproduction.
引用
收藏
页码:280 / 283
页数:4
相关论文
共 31 条
[21]  
Newmark S R, 1973, Urology, V2, P666, DOI 10.1016/0090-4295(73)90333-6
[22]   SUCCESSFUL TREATMENT OF CUSHINGS-SYNDROME WITH THE GLUCOCORTICOID ANTAGONIST RU-486 [J].
NIEMAN, LK ;
CHROUSOS, GP ;
KELLNER, C ;
SPITZ, IM ;
NISULA, BC ;
CUTLER, GB ;
MERRIAM, GR ;
BARDIN, CW ;
LORIAUX, DL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (03) :536-540
[23]  
Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2
[24]   Cabergoline plus lanreotide for ectopic Cushing's syndrome [J].
Pivonello, R ;
Ferone, D ;
Lamberts, SWJ ;
Colao, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23) :2457-2458
[25]   Hypokalemia, metabolic alkalosis, and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma [J].
Rickman, T ;
Garmany, R ;
Doherty, T ;
Benson, D ;
Okusa, MD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :838-846
[26]   Ectopic ACTH syndrome: our experience with 25 cases [J].
Salgado, Luiz Roberto ;
Fragoso, Maria Candida B. Villares ;
Knoepfelmacher, Mirta ;
Machado, Marcio Carlos ;
Domenice, Sorahia ;
Adelaide, Maria ;
Pereira, Albergaria ;
de Mendonca, Berenice Bilharinho .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (05) :725-733
[27]   New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma [J].
Sciarra, A ;
Cardi, A ;
Dattilo, C ;
Mariotti, G ;
Di Monaco, F ;
Di Silverio, F .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (04) :462-470
[28]   Neuroendocrine differentiation in prostate cancer [J].
Shariff, Amir H. ;
Ather, M. Hammad .
UROLOGY, 2006, 68 (01) :2-8
[29]   ACTH PRECURSORS CHARACTERIZE THE ECTOPIC ACTH SYNDROME [J].
STEWART, PM ;
GIBSON, S ;
CROSBY, SR ;
PENN, R ;
HOLDER, R ;
FERRY, D ;
THATCHER, N ;
PHILLIPS, P ;
LONDON, DR ;
WHITE, A .
CLINICAL ENDOCRINOLOGY, 1994, 40 (02) :199-204
[30]   Prognostic significance of plasma chromogranin A levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study [J].
Taplin, ME ;
George, DJ ;
Halabi, S ;
Sanford, B ;
Febbo, PG ;
Hennessy, KT ;
Mihos, CG ;
Vogelzang, NJ ;
Small, EJ ;
Kantoff, PW .
UROLOGY, 2005, 66 (02) :386-391